Repository logo
Communities & Collections
All of DSpace
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Nwude, D. O."

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Thumbnail Image
    Item
    Anti-measles potential of selected compounds from uvaria chamae P. beauv: a molecular docking approach
    (2024) Oluremi, B. B.; Osamudiamen, P. M.; Nwude, D. O.; Ajeoge, J. K.; Babatunde, A.
    Measles is an extremely contagious viral infection, reported to be responsible for most global childhood death. Plants have been proven to be very effective against viral diseases with an added advantage of less toxicity. Previous studies have reported the activities of Uvaria chamae extracts against measles virus. This study investigated the in silico anti-measles activities of bioactive compounds from Uvaria Chamae leaves extract. The in silico docking studies were carried out using four compounds isolated from U. chamae (stigmasterol, chrysin, chalcone, and dihydrochalcone) reported in literature. The pharmacokinetic properties of these selected compounds were also evaluated using ADMET studies. The compounds were docked to the measles virus nucleoprotein (PDB ID: 5E4V) and they had binding affinities ranging from -6.4 to -8.2 kcal/mol. Stigmasterol (-8.2 kcal/mol) and Chrysin (-8.0 kcal/mol) showed the greatest affinities for the protein target. These two compounds passed the Lipinski’s Rule of Five for leadlikeness. Stigmastrol and Chrysin showed promising pharmacological properties that indicate that they could be investigated as viable lead candidates for further anti-measles drug development studies.

DSpace software copyright © 2002-2026 Customised by Abba and King Systems LLC

  • Privacy policy
  • End User Agreement
  • Send Feedback
Repository logo COAR Notify